# Cullinan Therapeutics, Inc. (CGEM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Cullinan Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CGEM/mda/fy2025/): filed 2026-03-10; accession 0001193125-26-099362 (https://www.sec.gov/Archives/edgar/data/1789972/000119312526099362/cgem-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CGEM/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-028346 (https://www.sec.gov/Archives/edgar/data/1789972/000095017025028346/cgem-20241231.htm)
- [FY 2023 MD&A](/company/CGEM/mda/fy2023/): filed 2024-03-14; accession 0000950170-24-031143 (https://www.sec.gov/Archives/edgar/data/1789972/000095017024031143/cgem-20231231.htm)
- [FY 2022 MD&A](/company/CGEM/mda/fy2022/): filed 2023-03-09; accession 0000950170-23-006839 (https://www.sec.gov/Archives/edgar/data/1789972/000095017023006839/cgem-20221231.htm)
- [FY 2021 MD&A](/company/CGEM/mda/fy2021/): filed 2022-03-17; accession 0000950170-22-004002 (https://www.sec.gov/Archives/edgar/data/1789972/000095017022004002/cgem-20211231.htm)

Back to /company/CGEM/